Keystone Drug News: CoMentis BACE Inhibitor Debuts Keystone Drug News: Agonists for M1, Serotonin Receptors Prime Cholinergic Pump Keystone Drug News: Phase 2 Anti-oligomer Sugar Alcohol—How Might It Work? Keystone Drug News: Glimpse of Lilly’s Phase 1 Pa
In part 6 of our Keystone Symposia Meeting summary, Minji Kim, Alice Lu, and Rudy Tanzi relay new developments in tau biology and frontotemporal dementia...
In part 4 of our report, Minji Kim, Alice Lu, and Rudy Tanzi summarize presentations by Dennis Selkoe, Christian Haass, Bart De Strooper, Jie Shen, Homira Behbahani, and Taisuke Tomita...
This is part 3 of our report by Minji Kim, Alice Lu, and Rudy Tanzi. Sam Gandy, Thomas Jefferson University, Philadelphia, reviewed the trafficking pathways of APP from the endoplasmic reticulum (ER) to...
Part 2 of our report by Minji Kim, Alice Lu, and Rudy Tanzi. Steve Younkin, Mayo Clinic at Jacksonville, Florida, presented the recent progress in identification of...
Minji Kim, Alice Lu, and Rudy Tanzi report on the recent Keystone Symposium on Alzheimer disease, which focused on the molecular underpinnings of Alzheimer disease (AD) and frontal temporal dementia (FTD), covering...